Ogihara Koichiro 荻原広一郎

… Alternative Names

Researcher Number	30626677
Other IDs
Affiliation (Current)	2021: 慶應義塾大学, 医学部(信濃町), 共同研究員
Affiliation (based on the past Project Information) *help	2021: 慶應義塾大学, 医学部, 研究員 2018: 慶應義塾大学, 医学部(信濃町), 助教 2017 – 2018: 慶應義塾大学, 医学部(信濃町), 特任助教
Review Section/Research Field	Principal Investigator Urology / Basic Section 56030:Urology-related
Keywords	Principal Investigator 膀胱癌 / 癌幹細胞 / CD44 / sulfasalazine / シスプラチン / 膀胱内注入療法 / 癌 / 細胞・組織 / 発現制御 / トランスレーショナルリサーチ / 薬剤反応性

CD44v陽性癌幹細胞モデルを基盤とした新規膀胱内注入療法の確立Principal InvestigatorOngoing
- Principal Investigator
  
  荻原広一郎
- Project Period (FY)
  2021 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Keio University
The establishment of new therapeutic strategy for bladder cancer targeting to cancer stem cellPrincipal Investigator
- Principal Investigator
  
  Ogihara Koichiro
- Project Period (FY)
  2017 – 2018
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Urology
- Research Institution
  Keio University

All 2019 2018 2017

All Journal Article Presentation

[Journal Article] Sulfasalazine could modulate the CD44v9‐xCT system and enhance cisplatin‐induced cytotoxic effects in metastatic bladder cancer2019
- Author(s)
  Ogihara Koichiro、Kikuchi Eiji、Okazaki Shogo、Hagiwara Masayuki、Takeda Toshikazu、Matsumoto Kazuhiro、Kosaka Takeo、Mikami Shuji、Saya Hideyuki、Oya Mototsugu
- Journal Title
  
  Cancer Sci
  
  Volume: 110 Pages: 1431-1441
- DOI
  10.1111/cas.13960
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K15223, KAKENHI-PROJECT-16K08657, KAKENHI-PROJECT-17K16812, KAKENHI-PROJECT-19K07468, KAKENHI-PROJECT-17K11158
[Presentation] CD44 variant 9 expression is a novel indicator for identifying poor survival in patients with invasive urothelial carcinoma2019
- Author(s)
  Ogihara Koichiro、Kikuchi Eiji、Hagiwara Masayuki、Matsumoto Kazuhiro、Mikami Shuji、Saya Hideyuki、Oya Mototsugu
- Organizer
  The 114th American Urological Association Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K16812
[Presentation] The therapeutic effect of sulfasalazine for metastatic urothelial carcinoma targeting to cancer stem cell2018
- Author(s)
  Ogihara Koichiro、Kikuchi Eiji、Takeda Toshikazu、Kosaka Takeo、Saya Hideyuki、Oya Mototsugu
- Organizer
  The 77th Annual Meeting of the Japanese Cancer Association
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K16812
[Presentation] The establishment of new therapeutic strategy for metastatic urothelial carcinoma targeting to cancer stem cell.2018
- Author(s)
  Koichiro Ogihara
- Organizer
  The 16th Urological Association of Asia Congress 2018
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K16812
[Presentation] The establishment of new therapeutic strategy for metastatic urothelial carcinoma targeting to cancer stem cell2018
- Author(s)
  Ogihara Koichiro、Kikuchi Eiji、Okazaki Shogo、Hagiwara Masayuki、Takeda Toshikazu、Kosaka Takeo、Mikami Shuji、Saya Hideyuki、Oya Mototsugu
- Organizer
  The 16th Urological Association of Asia Congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K16812
[Presentation] The effect of sulfasalazine on bladder cancer stem like cells targeting to cystine transporter2017
- Author(s)
  荻原　広一郎
- Organizer
  第76回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K16812

1. KIKUCHI Eiji

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
2. 岡崎章悟

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
3. 三上修治

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
4. 小坂威雄

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Ogihara Koichiro 荻原 広一郎

荻原 広一郎 オギハラ コウイチロウ

Research Projects

Research Products

Co-Researchers

CD44v陽性癌幹細胞モデルを基盤とした新規膀胱内注入療法の確立Principal InvestigatorOngoing

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The establishment of new therapeutic strategy for bladder cancer targeting to cancer stem cellPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Sulfasalazine could modulate the CD44v9‐xCT system and enhance cisplatin‐induced cytotoxic effects in metastatic bladder cancer2019

Author(s)

Journal Title

DOI

Data Source

[Presentation] CD44 variant 9 expression is a novel indicator for identifying poor survival in patients with invasive urothelial carcinoma2019

Author(s)

Organizer

Data Source

[Presentation] The therapeutic effect of sulfasalazine for metastatic urothelial carcinoma targeting to cancer stem cell2018

Author(s)

Organizer

Data Source

[Presentation] The establishment of new therapeutic strategy for metastatic urothelial carcinoma targeting to cancer stem cell.2018

Author(s)

Organizer

Data Source

[Presentation] The establishment of new therapeutic strategy for metastatic urothelial carcinoma targeting to cancer stem cell2018

Author(s)

Organizer

Data Source

[Presentation] The effect of sulfasalazine on bladder cancer stem like cells targeting to cystine transporter2017

Author(s)

Organizer

Data Source

Ogihara Koichiro 荻原広一郎

荻原広一郎オギハラコウイチロウ